Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: Intermediate-term risk of recurrent neurological events

Catheterization and Cardiovascular Interventions

Volumn 55, Issue 2, 2002, Pages 189-194

  Du, Zhong Dong ^a   Cao, Qi Ling ^a   Joseph, Annette ^b   Koenig, Peter ^a   Heischmidt, Mary ^a   Waight, David J ^a   Rhodes, Jonathan ^b   Brorson, James ^c   Hijazi, Ziyad M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Device closure; PFO; Stroke; Transient ischemic attack

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; DEVICE; EMBOLISM; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; MALE; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ASPIRIN; CATHETERS, INDWELLING; CEREBROVASCULAR ACCIDENT; EMBOLISM, PARADOXICAL; FEMALE; FOLLOW-UP STUDIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 0036158507     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10067     Document Type: Article

References (18)

1. Prevalence of patent foramen ovale in patients with stroke
2. Patent foramen ovale in young stroke patients
3. Patent foramen ovale as a risk factor for cryptogenic stroke
4. Stroke recurrence in patients with patent foramen ovale: The Lausanne study
5. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm: Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack
6. Preventing stroke recurrence in patients with patent foramen ovale: Antithrombotic therapy, foramen closure, or therapeutic abstention? - A decision analytic perspective
7. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale
8. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism
9. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism
10. Two- and three-dimensional transesophageal echocardiography in patient selection and assessment of atrial septal defect closure by the new DAS-Angel Wings device: Initial clinical experience
11. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events
12. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement
13. Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting
14. Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices
15. Transvenous closure of secundum atrial septal defects: Preliminary results with a new self-expanding nitinol prosthesis in a swine model
16. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance feasibility and comparison with transesophageal echocardiography
17. Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurological events
18. Contrast two-dimensional echocardiography in congenital heart disease: Techniques, indications and clinical utility